kras mutation and glutathion KRAS-targeted therapies in cancer: novel approaches overcoming resistance KRAS mutation: from undruggable to
KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy Impact of KRAS mutation on the tumor microenvironment in colorectal cancer BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site specific metastasis by stimulating glutathione synthesis: Cell Reports Research advances in the treatment of KRAS mutant colorectal cancer from Prof. Guoquan Gao's group at Zhongshan School of Medicine SUN YAT SEN UNIVERSITY
Pay in 4 interest-free payments of $6.69 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



